Photomedex (PHMD) Misses Q2 EPS by 8c

Photomedex (NASDAQ: PHMD) reported Q2 EPS of $0.01, $0.08 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $52.1 million versus the consensus estimate of $62.1 million.

For earnings history and earnings-related data on Photomedex (PHMD) click here.

You May Also Be Interested In

• Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
• TAL Education (TAL) Tops Q1 EPS by 10c
• STMicroelectronics N.V. (STM) Misses Q1 EPS by 9c; offers Q2 outlook